Journal Article Summary
The article investigates the use of nanostructured lipid carriers (NLCs) to enhance the oral absorption of tizanidine (TNZ), a muscle relaxant commonly prescribed for spasticity. Tizanidine is classified as a Biopharmaceutics Classification System (BCS) class II drug, which means it has low solubility and poor oral bioavailability. Improving the absorption of TNZ is crucial because its effectiveness is limited by how much of the drug can be utilized by the body after ingestion.
In the study, researchers synthesized NLCs using microemulsion techniques and optimized their formulation by varying the concentrations of TNZ, lipids, and surfactants. They measured key parameters such as particle size, zeta potential, and entrapment efficiency. The optimized NLCs showed a mean particle size of 208 nm and an impressive entrapment efficiency of 93%. Importantly, the pharmacokinetic analysis revealed that the NLCs significantly enhanced the bioavailability of TNZ, achieving a 21-fold increase in the area under the curve (AUC) compared to the conventional TNZ suspension.
Despite the promising results, the study has limitations, including its reliance on animal models, which may not fully replicate human responses. Patients should consult healthcare professionals before considering any changes to their medication regimen, especially since the safety and efficacy of NLCs in humans have yet to be established. It is essential for patients to discuss potential benefits and risks with their doctors, particularly regarding the management of spasticity and the use of tizanidine.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Bazuhair Mohammed A., Jamal Maha H., Alashari Rawabi A., Ahmad Shakeel, Junaid Muhammad, Yasinzai Maimoona, Nawaz Muhammad Asif, Alzain Mohannad A., et al.. Nano-Engineered Cargo for Optimizing Oral Absorption of Tizanidine Nanostructured Lipid Carriers. Advanced Pharmaceutical Bulletin 2025. DOI: 10.34172/apb.025.45650. PMID: 41835048. PMCID: PMC12980190.
Featured Pill Pals Product
Tizanidine 2 mg Capsules --- Generic For Zanaflex --- Ascend
Tizanidine 2 mg Capsules — Generic For Zanaflex — Ascend is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
